We are excited to announce the first online seminar session in its upcoming series, featuring Dr. Driton Vllasaliu from King’s College London as a guest speaker. Dr. Vllasaliu will present his groundbreaking research on the oral delivery of RNA in a dedicated session “Engineered milk extracellular vesicles for oral delivery of RNA”, that will take place on 20 March. As Dr. Vllasaliu will showcase his work in translational drug delivery and oral administration of RNA utilising extracellular vesicles, the GENEGUT consortium will be presented with a unique opportunity to engage in insightful discussions around drug delivery systems to transform our approach to disease treatment. Stay tuned for more updates on the GENEGUT seminar series.
More about Dr. Driton Vllasaliu (King's College London)
Driton is a pharmacist and gained his PhD at the University of Nottingham. Driton’s research interests centre around understanding and overcoming the biological barriers to improve drug delivery, with a key focus on enabling injection-free administration of biotherapeutic drugs (peptides, proteins, nucleic acids). As part of this, he has specific interests in drug delivery systems, including nanomedicines and extracellular vesicles (exosomes), that potentially enable oral delivery. He is also interested in drug delivery for diseases of, or linked to, the gut. Finally, aspects of Driton’s research relate to the creation of improved (more predictive) in vitro models for use in medicines development, including organoids. Much of his current research focus is on oral delivery of RNA using extracellular vesicles.
UK participants in Horizon Europe Project GENEGUT are supported by UKRI grant number 10042451 (Bangor University).